TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12771499

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) with glass-ionomer
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Conventional approach with amalgam
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Modified-conventional approach with amalgam
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Conventional approach with glass-ionomer
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: All occlusal amalgam restorations
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: All glass-ionomer restorations
Number of subjects: 152

Group type: COMPARATOR
Intervention: Comparison of secondary caries
Number of subjects: 152
Study: 10702774

Group type: EXPERIMENTAL
Intervention: Group meetings
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Correspondence course
Number of subjects: 102

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 102
Study: 9179367

Group type: EXPERIMENTAL
Intervention: Viscum album agglutinin-I (10 and 1 ng/ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viscum album agglutinin-I (lectin-enriched preparation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Freshly isolated Viscum album agglutinin-I
Number of subjects: 0
Study: 8409723

Group type: EXPERIMENTAL
Intervention: Diathermy
Number of subjects: 1036

Group type: COMPARATOR
Intervention: Ligatures
Number of subjects: 1036
Study: 29708650

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 737

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 737
Study: 29096614

Group type: EXPERIMENTAL
Intervention: Socially-enhanced experimental condition (pedometer plus app with social and gamification features)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Basic experimental condition (pedometer plus basic app with no social and gamification features)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 440
Study: 26501386

Group type: EXPERIMENTAL
Intervention: 500 mg intraoperative methylprednisolone
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1043
Study: 23107996

Group type: EXPERIMENTAL
Intervention: Consistent information exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inconsistent information exposure
Number of subjects: 20
Study: 20929999

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (CGM) for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy for 4 weeks
Number of subjects: 0
Study: 18386049

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise countermeasure (RVE)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inactive control group (Ctrl)
Number of subjects: 16
Study: 16871570

Group type: EXPERIMENTAL
Intervention: TMA Assay (LOD 9.6 IU/mL)
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: Negative TMA results
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: Single positive TMA test
Number of subjects: 1145
Study: 12759295

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg, subcutaneously, twice weekly)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11120531

Group type: EXPERIMENTAL
Intervention: Methotrexate infusion therapy (100 mg/m² intravenous bolus followed by 200 mg/m² infusion)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Combination therapy (methotrexate, etoposide, and bleomycin)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 59
Study: 9256623

Group type: EXPERIMENTAL
Intervention: 0.12% isopropyl unoprostone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8211872

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1.5 mg per day
Number of subjects: 274

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate 1.5 mg per day
Number of subjects: 274
Study: 3102372

Group type: EXPERIMENTAL
Intervention: L-carnitine (4g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-carnitine (2g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no L-carnitine)
Number of subjects: 0
Study: 30975570

Group type: EXPERIMENTAL
Intervention: PHiD‐CV/dPly/PhtD (10 or 30 µg of each protein) with 3+0 schedule (2‐3‐4 months)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: PHiD‐CV/dPly/PhtD (30 µg of each protein) with 2+1 schedule (2‐4‐9 months)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: PHiD‐CV
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: DTPw‐HBV/Hib, OPV, measles, yellow fever vaccines co-administered with pneumococcal proteins
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Co-administered vaccines
Number of subjects: 1200
Study: 29627709

Group type: EXPERIMENTAL
Intervention: E/C/F/TAF
Number of subjects: 1733

Group type: COMPARATOR
Intervention: E/C/F/TDF
Number of subjects: 1733
Study: 26649812

Group type: EXPERIMENTAL
Intervention: Focused Enhanced Cognitive Behavior Therapy (CBT‐Ef)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Broad Enhanced Cognitive Behavior Therapy (CBT‐Eb)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both CBT‐Ef and CBT‐Eb
Number of subjects: 50
Study: 25319689

Group type: EXPERIMENTAL
Intervention: Bilateral contraction of homonymous (elbow flexor) muscles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral contraction of heteronymous (elbow flexor and extensor) muscles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medial rotation of the head
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral rotation of the head
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Head flexion and extension
Number of subjects: 0
Study: 22678326

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic colectomy (HALC)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 116
Study: 20297882

Group type: EXPERIMENTAL
Intervention: Expressive-supportive counseling groups (experimental group)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Wait-list control (control group)
Number of subjects: 164
Study: 17568955

Group type: EXPERIMENTAL
Intervention: Frequent-comprehensive assessment
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Frequent-brief assessment
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Infrequent-comprehensive assessment
Number of subjects: 235

Group type: COMPARATOR
Intervention: Infrequent-brief assessment
Number of subjects: 235
Study: 16151286

Group type: EXPERIMENTAL
Intervention: Single-shot fascia iliaca compartment block (FICB) with ropivacaine 0.2% for bolus and saline for infusion
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Continuous fascia iliaca compartment block (FICB) with ropivacaine 0.2% for bolus and infusion
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group with saline for both bolus and infusion
Number of subjects: 81
Study: 14753247

Group type: EXPERIMENTAL
Intervention: HFA-134a
Number of subjects: 270

Group type: COMPARATOR
Intervention: CFC
Number of subjects: 270
Study: 10533689

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Teaching at 3 hours after midazolam administration
Number of subjects: 20
Study: 9084546

Group type: EXPERIMENTAL
Intervention: Midazolam (0.06 mg/kg) and Propofol (20 mg/5 s) for induction; Propofol (8 mg/kg/hr) for maintenance
Number of subjects: 42

Group type: COMPARATOR
Intervention: Propofol (20 mg/5 s) for induction; Propofol (10 mg/kg/h) for maintenance
Number of subjects: 42
Study: 1875206

Group type: COMPARATOR
Intervention: Continuous Passive Motion (CPM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CPM with Continuous Cooling Pad (CCP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CPM with Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 100
Study: 6979255

Group type: EXPERIMENTAL
Intervention: Aroused condition
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Relaxed condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alert condition
Number of subjects: 24
Study: 30767407

Group type: EXPERIMENTAL
Intervention: Pre-test counselling for BRCA testing
Number of subjects: 935
Study: 28936963

Group type: EXPERIMENTAL
Intervention: Self made guidance for difficult gastric tube placement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (traditional gastric tube placement)
Number of subjects: 40
Study: 29182119

Group type: EXPERIMENTAL
Intervention: Poking reduction and cannulated screws fixation (Group A, N=28)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plate fixation using a sinus tarsi approach (Group B, N=22)
Number of subjects: 50
Study: 24949907

Group type: EXPERIMENTAL
Intervention: Single-session computer-assisted anxiety sensitivity intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 104
Study: 22629353

Group type: EXPERIMENTAL
Intervention: Fones technique
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Modified Bass technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (basics of tooth brushing)
Number of subjects: 56
Study: 19641457

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 17136042

Group type: EXPERIMENTAL
Intervention: cholesterol-reducing diet (high in plant sterols 1.0 g/1000 kcal, soy protein 22.5 g/1000 kcal, viscous fibers 10 g/1000 kcal, almonds 23 g/1000 kcal)
Number of subjects: 66
Study: 16446892

Group type: EXPERIMENTAL
Intervention: Epley Maneuver with post‐maneuver restrictions (23 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Epley Maneuver without post‐maneuver restrictions (27 patients)
Number of subjects: 50
Study: 11842353

Group type: EXPERIMENTAL
Intervention: Exercise training (passive range of motion exercise with gentle compression of both the upper and lower extremities, lasting 5-10 minutes each day, 5 days per week for 4 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 24
Study: 10077139

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg b.i.d.
Number of subjects: 233

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 200 microg b.i.d.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 233
Study: 7706804

Group type: EXPERIMENTAL
Intervention: Cidofovir alone at doses of 0.5, 1.0, 3.0, or 10.0 mg/kg/week (20 patients)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cidofovir at 3.0, 5.0, or 7.5 mg/kg with concomitant oral probenecid, saline prehydration, extended dosing intervals, and drug interruption for proteinuria (19 patients)
Number of subjects: 31
Study: 2037083

Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 1969

Group type: COMPARATOR
Intervention: Laboratory measurements (initial white cell count)
Number of subjects: 1969
Study: 6183894

Group type: EXPERIMENTAL
Intervention: 5% aluminium chloride hexahydrate in absolute alcohol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 11
Study: 31453944

Group type: EXPERIMENTAL
Intervention: RT + SE (static stretching after resistance training)
Number of subjects: 26

Group type: COMPARATOR
Intervention: SE + RT (static stretching before resistance training)
Number of subjects: 26

Group type: COMPARATOR
Intervention: RTSE (static stretching between resistance training)
Number of subjects: 26
Study: 27876342

Group type: EXPERIMENTAL
Intervention: Ciprofibrate 100 mg/d for 12 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 1800 mg/d for 12 weeks
Number of subjects: 29
Study: 26359536

Group type: EXPERIMENTAL
Intervention: Drinking ≥4 cups/day of black tea
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Never drinking black tea
Number of subjects: 1325
Study: 24192428

Group type: EXPERIMENTAL
Intervention: Higher Kt/V
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Higher dialyzer mass transfer-area coefficient for urea
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Rate of urea removal
Number of subjects: 1825
Study: 21438784

Group type: EXPERIMENTAL
Intervention: Du-14 acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Li-11 acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: St-36 acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sp-6 acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90
Study: 19122976

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 77

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 77
Study: 17694045

Group type: EXPERIMENTAL
Intervention: Discontinued warfarin (group 1)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Suturing and discontinued warfarin (group 3)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Continued warfarin (group 2)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Suturing and continued warfarin (group 4)
Number of subjects: 214
Study: 15369533

Group type: EXPERIMENTAL
Intervention: Labeling the correct color before responding (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pointing to the large card (Experiment 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decreasing affective salience of stimuli (colored beads vs. Smarties) (Experiment 3)
Number of subjects: 0
Study: 10994916

Group type: EXPERIMENTAL
Intervention: Cyclists (C) at 100 W
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Runners (R) at 100 W
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Less-trained noncyclists (LT) at 75 W
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Less-trained noncyclists (LT) at 100 W
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Less-trained noncyclists (LT) at 150 W
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cyclists (C)
Number of subjects: 31

Group type: COMPARATOR
Intervention: All groups (C, R, LT)
Number of subjects: 31
Study: 9298081

Group type: EXPERIMENTAL
Intervention: Full intervention (computer-generated reminders promoting physician referral for mammography)
Number of subjects: 1225

Group type: COMPARATOR
Intervention: Limited intervention (out-of-pocket mammography cost eliminated)
Number of subjects: 1225
Study: 10146804

Group type: EXPERIMENTAL
Intervention: Cholesterol reduction programs
Number of subjects: 587
Study: 4072339

Group type: EXPERIMENTAL
Intervention: Mnemonic device (method of loci)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study: 31888670

Group type: EXPERIMENTAL
Intervention: 3-marker diagnostic model (IDH1, SHOX2, PTGER4)
Number of subjects: 221

Group type: COMPARATOR
Intervention: 2-marker model
Number of subjects: 221
Study: 30077809

Group type: EXPERIMENTAL
Intervention: Symbicort® pMDI 160/4.5 μg/actuation (2 actuations) with AeroChamber Plus® Flow‐Vu® spacer
Number of subjects: 50

Group type: COMPARATOR
Intervention: Symbicort® pMDI 160/4.5 μg/actuation (2 actuations) without spacer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In vitro study with AeroChamber Plus® Flow‐Vu® spacer
Number of subjects: 50

Group type: COMPARATOR
Intervention: In vitro study without spacer
Number of subjects: 50
Study: 27050796

Group type: EXPERIMENTAL
Intervention: Switch from ticagrelor to clopidogrel
Number of subjects: 586
Study: 24674663

Group type: EXPERIMENTAL
Intervention: HPV-16/18/31/45 AS04 vaccine containing 20/20/10/10 μg VLPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV-16/18/33/58 AS04 vaccine containing 20/20/20/20 μg VLPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetravalent AS04 vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (licensed HPV-16/18 AS04-adjuvanted vaccine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetravalent vaccines with additional VLPs
Number of subjects: 0
Study: 22451195

Group type: EXPERIMENTAL
Intervention: FOLFOX/FOLFIRI sequential chemotherapy
Number of subjects: 0
Study: 20882929

Group type: EXPERIMENTAL
Intervention: Weighted vest (4-5 kg for 2 weeks, 8-10 kg for 4 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no vest)
Number of subjects: 43
Study: 19035721

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine (5-15 mg/hour)
Number of subjects: 30
Study: 16175758

Group type: EXPERIMENTAL
Intervention: Life Goals Program (collaborative care model)
Number of subjects: 0
Study: 14512476

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 301

Group type: COMPARATOR
Intervention: Haloperidol plus promethazine
Number of subjects: 301
Study: 10713577

Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase inhibitors (ChIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9239913

Group type: EXPERIMENTAL
Intervention: 2 mg oestradiol valerate and 2.5 mg medroxyprogesterone acetate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1499248

Group type: EXPERIMENTAL
Intervention: Slow-release varnish containing chlorhexidine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 7
Study: 761675

Group type: EXPERIMENTAL
Intervention: Progestasert (UPS)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Nova-T
Number of subjects: 326

Group type: COMPARATOR
Intervention: Both IUDs
Number of subjects: 326
Study: 30291370

Group type: EXPERIMENTAL
Intervention: Topical atorvastatin 1%
Number of subjects: 70
Study: 27617502

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (27 mg per day for 8 weeks)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (320 mg per day for 8 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (daily for 8 weeks)
Number of subjects: 99
Study: 25808783

Group type: EXPERIMENTAL
Intervention: Anxiety sensitivity
Number of subjects: 396
Study: 23007491

Group type: EXPERIMENTAL
Intervention: Ventilatory Threshold (VT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Equivocal Stage (EQ)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Respiratory Compensation Threshold (RCT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Negative Stage (NEG)
Number of subjects: 18
Study: 21372038

Group type: EXPERIMENTAL
Intervention: Sulforaphane-rich beverage (SFR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Glucoraphanin-rich beverage (GRR)
Number of subjects: 50
Study: 19147689

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concomitant anthracycline therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reintroduction of trastuzumab after resolution of normal cardiac function
Number of subjects: 0
Study: 17377117

Group type: EXPERIMENTAL
Intervention: Abduction group (arm in abduction)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adduction group (arm in adduction)
Number of subjects: 0
Study: 16332430

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) as an add-on treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no LEV)
Number of subjects: 35
Study: 14639483

Group type: EXPERIMENTAL
Intervention: Pressure bandage for 1 week followed by immediate mobilization
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ulnar gutter plaster cast for 3 weeks followed by mobilization
Number of subjects: 35
Study: 10365896

Group type: EXPERIMENTAL
Intervention: TUBT (tablet-based 13C urea breath test)
Number of subjects: 134

Group type: COMPARATOR
Intervention: SUBT (standard 13C urea breath test)
Number of subjects: 134
Study: 7578166

Group type: EXPERIMENTAL
Intervention: simvastatin 10 mg daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: gemfibrozil 600 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: cholestyramine 4 gm twice daily
Number of subjects: 48
Study: 2272022

Group type: EXPERIMENTAL
Intervention: Apomorphine (10 micrograms/kg subcutaneously with oral domperidone 10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral sultopride (50 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7000282

Group type: EXPERIMENTAL
Intervention: Health education booklet describing the management of six common symptoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health education booklet
Number of subjects: 0
Study: 29621885

Group type: EXPERIMENTAL
Intervention: Far-infrared garments
Number of subjects: 20
Study: 27307483

Group type: EXPERIMENTAL
Intervention: Minimally invasive extracorporeal circulation (MiECC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (cCPB)
Number of subjects: 60
Study: 23972505

Group type: EXPERIMENTAL
Intervention: Topical 0.2% nitroglycerin ointment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open partial lateral anal sphincterotomy
Number of subjects: 60
Study: 22357861

Group type: EXPERIMENTAL
Intervention: Test and mask stimuli with distinct temporal frequencies; specific details on dosage and duration not applicable.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test and mask stimuli with equal contrast; specific details on dosage and duration not applicable.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divisive gain control models with 30 ms integration time; specific details on dosage and duration not applicable.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contrast normalization; specific details on dosage and duration not applicable.
Number of subjects: 0
Study: 20705780

Group type: EXPERIMENTAL
Intervention: AutoFlow assist-controlled ventilation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional assist-controlled ventilation
Number of subjects: 42
Study: 18060342

Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no infliximab therapy)
Number of subjects: 10
Study: 15788330

Group type: EXPERIMENTAL
Intervention: Neuroprosthesis group (NESS Handmaster)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 12495435

Group type: EXPERIMENTAL
Intervention: CCCT(1/4)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CCCT(1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: S1/S2
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: T1/M1
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: D/S
Number of subjects: 67